Immunization News and Research

RSS

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

A new study published on the bioRxiv preprint server has hypothesized that T cell receptors (TCR) repertoire can measure the response to vaccines, as it would identify the TCR of clones that respond to the vaccination.

13 Dec 2021

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

In a recent observational study, scientists have described the characteristics of VBIs in fully vaccinated individuals in France.

13 Dec 2021

COVID-19 pandemic may halt two decades of global progress towards Universal Health Coverage

New evidence compiled by the World Health Organization and the World Bank shows that the COVID-19 pandemic is likely to halt two decades of global progress towards Universal Health Coverage.

13 Dec 2021

SARS-CoV-2 omicron variant may evade host immune responses

A recent study has demonstrated that the omicron variant of severe acute respiratory syndrome coronavirus 2 has a higher ability to evade antibody-mediated neutralization than other variants of concern.

13 Dec 2021

Researchers develop a universal SARS-CoV-2 neutralizing antibody

A new study has been published in Frontiers in Immunology, where scientists developed a universal SARS-CoV-2 neutralizing antibody, MG1141A.

13 Dec 2021

MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice

A new mouse study found that intranasal administration of MV130 protected against severe acute respiratory syndrome coronavirus 2.

13 Dec 2021

Genetic-code expansion technique to potentially create next-generation vaccine candidate

A new experiment devised a novel method to manipulate virulent viruses in conventional laboratories and validated the prophylactic effect of this method in two mouse models.

13 Dec 2021

Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations

Study reveals that the most beneficial vaccination strategy is to distribute all available doses of COVID-19 vaccines predominantly for primary vaccinations and the remaining doses for boosters.

12 Dec 2021

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

The emergence of COVID-19 variants such as delta and omicron have sent scientists scrambling to determine whether existing vaccinations and boosters are still effective against new strains of SARS-Cov-2.

11 Dec 2021

Neutralizing antibody response against SARS-CoV-2 variants in health care workers pre- and post-vaccination

Researchers examined neutralizing antibody levels in 48 vaccinated health care workers against the major SARS-CoV-2 variants.

10 Dec 2021

Researchers receive $100,000 grant for new project on community health workers

For Department of Kinesiology and Community Health researchers Andiara Schwingel and Susan Aguiñaga, the concept of helping place Community Health Workers has a personal meaning.

9 Dec 2021

Long term vaccine response following Pfizer COVID-19 vaccination in hemodialysis patients

Researchers discuss the long-term humoral immune responses in hemodialysis patients after being vaccinated with the BNT162b2 mRNA vaccine.

9 Dec 2021

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

A review article focuses on the efficacy of neutralizing antibodies and vaccines against the SARS-CoV-2 variants.

9 Dec 2021

Increased risk of COVID-19 breakthrough infections in fully vaccinated people with HIV

New study results showed a 41% greater incidence of breakthrough infections in people with HIV compared to that of people without HIV.

9 Dec 2021

For most young people, COVID vaccine-related myocarditis is not serious

A new study published in the journal Circulation aimed to describe a large case series of suspected myocarditis temporally related with the COVID-19 vaccine in adolescents and young adults below 21 years of age across the United States and Canada.

8 Dec 2021

Neutralization antibodies elevated in nursing home residents after COVID-19 mRNA boosters

Researchers from the United States, in their recent study published on the preprint server medRxiv*, have evaluated the humoral responses to third vaccine dose in nursing home residents and healthcare workers (HCW) and found that that second booster (or third vaccine dose) significantly increased anti-spike, anti-receptor binding domain (RBD), and neutralization titers in almost all nursing home residents and HCW to considerably higher levels than what was attained after the completion of the initial two-dose vaccine series.

8 Dec 2021

WHO welcomes Gavi Alliance Board's historic decision to invest in first malaria vaccine

WHO welcomes the historic decision by the Gavi Alliance Board to invest in the first malaria vaccine programme.

8 Dec 2021

Routine immunization coverage declined in first year of COVID

A new study published on the medRxiv* preprint server investigated changes in RI coverage using two key indicators – diphtheria-tetanus-pertussis first-dose (DTP1) and third-dose (DTP3). DTP3 serves as a general marker for immunization system performance, while DTP1 is used as a proxy for inequity - quantifying Zero Dose (ZD) children––those that receive no childhood vaccinations

8 Dec 2021

Homologous mRNA and heterologous vaccines elicit high immune responses

New study findings show that homologous mRNA or heterologous vaccination induces the highest immune responses due to high RBD- and S1-specific antibodies.

7 Dec 2021

Comparison of waning COVID-19 immunity between vaccinated and infected individuals

The current study compares the waning of immunity in infected-and-recovered vs. vaccinated cohorts.

7 Dec 2021

Immunization News and Research

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Characteristics of vaccine breakthroughs in fully vaccinated individuals in France with delta variant

COVID-19 pandemic may halt two decades of global progress towards Universal Health Coverage

SARS-CoV-2 omicron variant may evade host immune responses

Researchers develop a universal SARS-CoV-2 neutralizing antibody

MV130 immunotherapy boosts natural and vaccine-induced SARS-CoV-2 immunity in mice

Genetic-code expansion technique to potentially create next-generation vaccine candidate

Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

Neutralizing antibody response against SARS-CoV-2 variants in health care workers pre- and post-vaccination

Researchers receive $100,000 grant for new project on community health workers

Long term vaccine response following Pfizer COVID-19 vaccination in hemodialysis patients

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Increased risk of COVID-19 breakthrough infections in fully vaccinated people with HIV

For most young people, COVID vaccine-related myocarditis is not serious

Neutralization antibodies elevated in nursing home residents after COVID-19 mRNA boosters

WHO welcomes Gavi Alliance Board's historic decision to invest in first malaria vaccine

Routine immunization coverage declined in first year of COVID

Homologous mRNA and heterologous vaccines elicit high immune responses

Comparison of waning COVID-19 immunity between vaccinated and infected individuals

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News